4/A: Becton Dickinson Executive Amends Stock Transaction Filing

An amended SEC filing reveals a correction to a previous stock transaction by Becton Dickinson's EVP and General Counsel, Michelle Quinn, regarding rights to common stock under a deferred compensation plan.

Summary

• This document is an amended SEC Form 4, filed by Michelle Quinn, EVP and General Counsel of Becton Dickinson & Co.
• The amendment corrects a previous filing from November 29, 2024, regarding the number of derivative securities beneficially owned.
• The transaction involves rights to 416 shares of common stock under a deferred compensation plan, acquired on November 26, 2024, at a price of $224.25 per share.
• The corrected filing shows that Ms. Quinn directly owns 416 derivative securities related to the deferred compensation plan.

Sentiment

Score: 7

Explanation: The document is a routine correction of a previous filing, indicating no significant positive or negative sentiment. It is a standard compliance procedure.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies, and the reporting requirements are standardized by the SEC.
• Similar filings are made by executives at companies like Medtronic (MDT) and Abbott Laboratories (ABT), which are also in the medical device industry.

Stakeholder Impact

• This filing provides transparency to shareholders regarding executive stock transactions.
• The correction has no material impact on the company's operations or financial position.

Key Dates

Keywords

SEC Filing, Form 4, Beneficial Ownership, Becton Dickinson, Stock Transaction, Derivative Securities, Deferred Compensation, Michelle Quinn